Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals, Inc.verified

PTPI

Price:

$0.2699

Market Cap:

$2.70M

Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals, Inc. is based in New York, New York.[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2020-12-02

Stock Exchange

NASDAQ

Ticker

PTPI

The Enterprise Value as of November 2024 (TTM) for Petros Pharmaceuticals, Inc. (PTPI) is 6.06M

According to Petros Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.06M. This represents a change of 99.87% compared to the average of 3.03M of the last 4 quarters.

Petros Pharmaceuticals, Inc. (PTPI) Historical Enterprise Value (quarterly & annually)

How has PTPI Enterprise Value performed in the past?

The mean historical Enterprise Value of Petros Pharmaceuticals, Inc. over the last ten years is 19.25M. The current 6.06M Enterprise Value has changed 3.05% with respect to the historical average. Over the past ten years (40 quarters), PTPI's Enterprise Value was at its highest in in the December 2020 quarter at 38.68M. The Enterprise Value was at its lowest in in the September 2023 quarter at -5614972.36.

Quarterly (TTM)
Annual

Average

19.25M

Median

15.61M

Minimum

-1992200.03

Maximum

48.39M

Petros Pharmaceuticals, Inc. (PTPI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Petros Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 77.90%

Maximum Annual Enterprise Value = 48.39M

Minimum Annual Increase = -138.78%

Minimum Annual Enterprise Value = -1992200.03

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023-1992200.03-138.78%
20225.14M-59.92%
202112.82M-60.85%
202032.75M77.90%
201918.41M-61.96%

Petros Pharmaceuticals, Inc. (PTPI) Average Enterprise Value

How has PTPI Enterprise Value performed in the past?

The current Enterprise Value of Petros Pharmaceuticals, Inc. (PTPI) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

5.32M

5-year avg

13.42M

10-year avg

19.25M

Petros Pharmaceuticals, Inc. (PTPI) Enterprise Value vs. Peers

How is PTPI’s Enterprise Value compared to its peers?

Petros Pharmaceuticals, Inc.’s Enterprise Value is greater than Sunshine Biopharma, Inc. (-6930906.00), greater than Guardion Health Sciences, Inc. (-10475955.00), greater than Sonoma Pharmaceuticals, Inc. (-17365.00), less than Alpha Teknova, Inc. (415.19M), greater than Evoke Pharma, Inc. (95.39K), less than Cumberland Pharmaceuticals Inc. (18.90M), less than Agile Therapeutics, Inc. (7.87M), greater than PainReform Ltd. (-1080859.00), less than Mallinckrodt plc (2.67B), less than Lifecore Biomedical, Inc. (400.55M), greater than Lucy Scientific Discovery Inc. (2.06M), less than Alimera Sciences, Inc. (362.58M), greater than Adamis Pharmaceuticals Corporation (-6593458674.00), less than China Pharma Holdings, Inc. (7.00M), less than Halo Collective Inc. (16.67M), greater than China SXT Pharmaceuticals, Inc. (-8091895.00), greater than Akanda Corp. (-3717101.00), greater than GelStat Corporation (837.32K), greater than Shuttle Pharmaceuticals Holdings, Inc. (3.60M),

Build a custom stock screener for Petros Pharmaceuticals, Inc. (PTPI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Petros Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Petros Pharmaceuticals, Inc. (PTPI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Petros Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Petros Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Petros Pharmaceuticals, Inc. (PTPI)?

What is the 3-year average Enterprise Value for Petros Pharmaceuticals, Inc. (PTPI)?

What is the 5-year average Enterprise Value for Petros Pharmaceuticals, Inc. (PTPI)?

How does the current Enterprise Value for Petros Pharmaceuticals, Inc. (PTPI) compare to its historical average?